Large-scale testing (Phase 3)Study completedNCT01017952
What this trial is testing
Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,635